Ann: Admedus to divest part of Infusion business, page-17

Hi Dabru, imagine we are ‘stuck’ with the necessity of this ‘bridging loan’ mate, deal to be finalised, perhaps, by end of May, we all too well know how these deadlines can blow out!

The AI sale falling thru’ still fresh in our memories, this current deal all conditional on the four key terms (as per announcement) being met, once signed then we can start counting our ‘chickens’.

I would interested to hear what the remainder of the business would be worth and revenue figures for it, wonder if this will be clarified at the AGM?

Any clues at AGM on interim funds meanwhile?, be nice/vital to see the prospect of a further CR knocked on the head.

Hope this suspension stays in effect till this is sorted out, need as much positive news prior to return of trading otherwise the effect on the sp will not be ‘pretty’, imo.